DeLong Mark Jeffrey
CIK 0001856078Chief Business & Strat Officer
Filings
5
Latest Mar 19, 2024
Issuers covered
1
Showing
5 of 5
Page 1
Issuers
Companies where DeLong Mark Jeffrey has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 5 | Mar 19, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 19, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 9,913 | $56.90 | $564,050 | |
| Feb 13, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 597 | $67.7669 | $40,457 | |
| Jan 31, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 367 | $64.1382 | $23,539 | |
| Jan 23, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 1,384 | $64.996 | $89,954 | |
| Jan 17, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 1,631 | $66.8086 | $108,965 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.